SHH and neoplasm: As a putative tumour-propagating cell marker, elevated CD24 expression has been documented in lung, breast, ovarian and brain cancers [52–56], and has been affiliated with high Shh/Ptch1 pathway activity in both colorectal cancer and medulloblastoma formation [57, 58].